JEST
COGT icon

JTC Employer Solutions Trustee’s Cogent Biosciences COGT Stock Holding History

JTC Employer Solutions Trustee’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-78,400
Closed -$3.02M – 310
2025
Q4 		$3.02M Buy
+78,400
New +$2.2M 0.21% 42

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

JTC Employer Solutions Trustee's COGT Position: Q1 2026 in Review

JTC Employer Solutions Trustee sold out of Cogent Biosciences (COGT) in Q1 2026, closing a stake of 78,400 shares — an estimated $3.02M sold.

JTC Employer Solutions Trustee first reported a position in COGT in Q4 2025 and held it in 1 quarter. The position peaked at $3.02M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • JTC Employer Solutions Trustee reported no remaining Cogent Biosciences position as of Q1 2026 after selling out during the quarter.
  • JTC Employer Solutions Trustee sold 78,400 Cogent Biosciences shares in Q1 2026, an estimated $3.02M.
  • JTC Employer Solutions Trustee first reported a position in Cogent Biosciences in Q4 2025 and held it in 1 quarter.
  • JTC Employer Solutions Trustee's Cogent Biosciences position peaked at $3.02M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q1 2026, filed 19 May 2026.